Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
July 24, 2014, 02:14:26 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 631660
  • Total Topics: 47817
  • Online Today: 231
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 4
Guests: 170
Total: 174

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: MK-0518 aka raltegravir: study report and expanded access  (Read 1479 times)

0 Members and 1 Guest are viewing this topic.

Offline newt

  • Member
  • Posts: 3,877
  • the one and original newt
MK-0518 aka raltegravir: study report and expanded access
« on: April 23, 2007, 09:46:32 AM »
Raltegravir (MK-0518) Phase 3 trials show successful viral suppression in multi-drug resistant patients

Simon Collins, i-Base reports on this study from the recent Conference on Retroviruses Opportunistic Infections (CROI) in the latest HIV Treatment Bulletin.  He begins his comment on this report:

"Using RGV with T-20 and DRV [Prezista] reduced viral load to <400 copies/mL in 98% of these highly treatment experienced patients. These results are startlingly high even given that this is only 16 week data because we are accustomed to sub-optimal response to treatment in both first line and MDR therapy. But these are the results that we should be looking for from treatment, given that 3 sensitive drugs including two entirely new classes were being used, and that adherence is likely to be very high in such advanced patients in a clinical trial."

Goes on to add a cavet about rapid resistance in people failing to achieve viral suppression though...

Expanded access programme details at www.earmrk.com

- matt
"The object is to be a well patient, not a good patient"

Offline Miss Philicia

  • Member
  • Posts: 23,874
  • celebrity poster, faker & poser
Re: MK-0518 aka raltegravir: study report and expanded access
« Reply #1 on: April 23, 2007, 12:34:28 PM »
Cool.  Thanks Matt.  I'm on t-20 and prezista now so I should keep this bookmarked.  My ID doctor is one of the top guys that does clinical trial in my area so I'll be sure to bring this up on my next visit, though I think he already may have mentioned it to me as an option if my numbers start going wonky, which fortunately they have not.
« Last Edit: April 23, 2007, 01:14:52 PM by philly267 »
"Ive slept with enough men to know that Im not gay"

Offline Rusty

  • Member
  • Posts: 28
Re: MK-0518 aka raltegravir: study report and expanded access
« Reply #2 on: May 12, 2007, 04:50:52 PM »
Hi

I am currently taking Prezista ,TMC 125 & Truvada. My viral load is undectable and my CD4 is 105.( never been very high) I have been infected for 23 years and am treatment experianced. My consultants want me to add Raltegravir (MK 0518). Does anyone think I would benefit from doing this or should I leave it alone. I was on Fuzeon for 18 months previously but stopped it because of severe injection site reactions and replaced this with TMC 125.

Any comments would be helpful

Rusty

Offline newt

  • Member
  • Posts: 3,877
  • the one and original newt
Re: MK-0518 aka raltegravir: study report and expanded access
« Reply #3 on: May 14, 2007, 05:03:21 AM »
Rusty

No, perhaps and yes...

1. NO. As your viral load is undetectable adding raltegravir will not improve the effectiveness of your combo. Prezista is a stunning drug resistance wise and prob. doing most of the work. Adding raltegravir ain;t gonna make this combo hugely (or indeed any) more effective.

2. PERHAPS. Your doc might be hoping for a CD4 increase.  The studies for raltegravir saw good CD4 increases in many people, but whether this is because of some magic immunological property of integrase inhibitors or because they got their viral load right down is not at all clear.

3. YES. If you have resistance that means the nukes and non-nuke (TMC 125) have a low barrier to resistance, your doc may think adding raltegravir will prevent further resistance emerging. This is a very good point, and worth exploring.  But maybe this is a "swap" rather than "add" discussion. Needs clarifying.

Hope this helps

- matt
"The object is to be a well patient, not a good patient"

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.